A number of firms have modified their ratings and price targets on shares of NewLink Genetics (NASDAQ: NLNK) recently: 4/16/2018 – NewLink Genetics was given a new $7.00 price target on by analysts at Cantor Fitzgerald. They now have a “hold” rating on the stock. They wrote, “Data from a Phase I study of indoximod […]
